The Albanese Government's action to ensure early patient access to a yet-to-be-approved treatment for high-risk neuroblastoma and the absence of any formal agreement with the company demonstrate the apparent simplicity of establishing a 'bridging' fund. …
The combination of political will and trust paving the way forward on access
July 19, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Nobody can possibly sustain an argument this is not a price negotiation
August 15, 2025 - - Latest News -
When it comes to PBAC outcomes, it's all in the language, about pricing
August 15, 2025 - - Latest News -
Interim report calls for prevention focus to boost the nation's productivity
August 14, 2025 - - Latest News -
Just because the system involves humans, it does not make it human
August 14, 2025 - - Latest News -
Australian company Mirugen secures backing to process cell technology
August 13, 2025 - - Latest News -
AccessCR’s awards celebrate partnerships between lived experience and science
August 13, 2025 - - Latest News -
Firebrick says Nasodine COVID-19 patent accepted in Europe
August 13, 2025 - - Australian Biotech